276 related articles for article (PubMed ID: 23441721)
1. Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study.
Honohan A; van't Ende E; Hulzebos C; Lopriore E; van't Verlaat E; Govaert P; Brand A; van der Bom J
Transfusion; 2013 Dec; 53(12):3100-9. PubMed ID: 23441721
[TBL] [Abstract][Full Text] [Related]
2. Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.
Bakchoul T; Bassler D; Heckmann M; Thiele T; Kiefel V; Gross I; Arnold DM; DiTomasso J; Smith JW; Paes B; Greinacher A
Transfusion; 2014 Mar; 54(3):640-5. PubMed ID: 23869512
[TBL] [Abstract][Full Text] [Related]
3. Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions.
Drawz SM; Marschner S; Yañez M; García de Coca A; Feys HB; Deeren D; Coene J
Transfusion; 2015 Jul; 55(7):1745-51. PubMed ID: 25702711
[TBL] [Abstract][Full Text] [Related]
4. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
[TBL] [Abstract][Full Text] [Related]
5. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
[TBL] [Abstract][Full Text] [Related]
7. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials.
Cid J; Lozano M
Transfusion; 2007 Mar; 47(3):464-70. PubMed ID: 17319827
[TBL] [Abstract][Full Text] [Related]
8. A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients.
Honohan A; Tomson B; van der Bom J; de Vries R; Brand A
Transfusion; 2012 Apr; 52(4):742-51. PubMed ID: 21981629
[TBL] [Abstract][Full Text] [Related]
9. Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.
van Hout FMA; van der Meer PF; Wiersum-Osselton JC; Middelburg RA; Schipperus MR; van der Bom JG; Kerkhoffs JL
Transfusion; 2018 Apr; 58(4):1021-1027. PubMed ID: 29405304
[TBL] [Abstract][Full Text] [Related]
10. Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial.
Heddle NM; Cook RJ; Blajchman MA; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Kelton JG
Transfusion; 2005 Jun; 45(6):896-903. PubMed ID: 15934987
[TBL] [Abstract][Full Text] [Related]
11. Patient and product factors affecting platelet transfusion results.
Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
[TBL] [Abstract][Full Text] [Related]
12. Use and safety of riboflavin and UV light-treated platelet transfusions in children over a five-year period: focusing on neonates.
Jimenez-Marco T; Garcia-Recio M; Girona-Llobera E
Transfusion; 2019 Dec; 59(12):3580-3588. PubMed ID: 31587287
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
Cameron B; Rock G; Olberg B; Neurath D
Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
Wiita AP; Nambiar A
Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
[TBL] [Abstract][Full Text] [Related]
15. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion.
Rioux-Massé B; Cohn C; Lindgren B; Pulkrabek S; McCullough J
Transfusion; 2014 Dec; 54(12):3080-7. PubMed ID: 24916382
[TBL] [Abstract][Full Text] [Related]
16. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit.
Gerday E; Baer VL; Lambert DK; Paul DA; Sola-Visner MC; Pysher TJ; Christensen RD
Transfusion; 2009 Oct; 49(10):2034-9. PubMed ID: 19555422
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion.
Enein AA; Hussein EA; El Shafie S; Hallouda M
J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120
[TBL] [Abstract][Full Text] [Related]
18. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
19. Platelet function in variable platelet split products intended for neonatal transfusion.
Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
[TBL] [Abstract][Full Text] [Related]
20. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
Julmy F; Ammann RA; Taleghani BM; Fontana S; Hirt A; Leibundgut K
Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
